Disease activity assessment in large vessel vasculitis;Valutazione dell'attività di malattia nelle vasculiti dei grandi vasi

Reumatismo

Volumn 63, Issue 2, 2011, Pages 86-90

  Magnani, L ^a   Versari, A ^a   Salvo, D ^a   Casali, M ^a   Germano G ^a   Meliconi, R ^b   Pulsatelli, L ^c   Formisano, D ^a   Bajocchi, G ^a   Pipitone, N ^a   Boiardi, L ^a   Salvarani, C ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Disease assessment; GCA; Interleukine 6; Large vessel vasculitis; Pet; Takayasu arteritis

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INDIAN TAKAYASU ACTIVITY SCORE; KERR NATIONAL INSTITUTE OF HEALTH INDICES; LARGE VESSEL VASCULITIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; VASCULITIS;

EID: 79960571732     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2011.86     Document Type: Article

References (14)

1. Gonzàles-Gay MA, Garcia-Porruea C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001; 27: 729-49.
2. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 Criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-8.
3. Arend WP, Michael BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 Criteria for the Classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129-34.
4. Arnaud L, Haroche J, Malek Z, Archambaud F, et al. Is 18FDG Pet scanning reliable Way to Assess Disease Activity in Takayasu Arteritis? Arthritis and Rheumatism 2009; 60: 1193-1200.
5. Pipitone N., Versari A., Salvarani C. Role of Imaging studies in the diagnosis and followup of large-vessel vasculitis: an update. Rheumatology 2008; 47: 403-8.
6. Jover JA, Hernandez-Garcia C, Morado IC. Combined treatment of giant cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001; 134: 106-14.
7. Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, et al. Infliximab for maintenance of glucocorticosteroid- induced remission of giant cell arteritis: a randomized trial. Ann Rheum Dis 2008; 67: 1567-9.
8. Noris M, Daina E, Gamba S, Bonazzola S, Remuzzi G. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 1999; 100: 55-60.
9. Nishimoto N, Nakara H, Yoshio-hoshino N, Mima T. Successful treatment of a patient with takayasu arteritis using a humanized Anti-Interleukin-6 antibody Artrithis Rheum 2008; 4: 1197-200.
10. Walter MA, Melzer RA, Christian S. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005; 32: 674-81.
11. Misra R, Danda D, Jayaseelan L. ITAS and DEI.TAK - Scores for clinical disease activity and damage extent in Takayasu aortoarteritis (TA). Rheumatology (Oxford) 2008; 47: ii101.
12. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994; 120: 919-29.
13. Salvarani C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, et al. Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis. J Rheumatol 2005; 32: 2173-7.
14. Salvarani C, Cantini F, Boiardi L, Hunder GG. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol 2003; 21(6 Suppl 32): S23.